Given the obvious differences in these confounders between healthy individuals and those with type 2 diabetes, there does not seem to be a fundamental difference in how GIP and GLP-1 influence glucagon secretion in healthy individuals compared with those with type 2 diabetes. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.